Skip to main content
    S

    STERIS plc (STE)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $262.05
    -2.27 (-0.86%)

    Market Cap: $25.67B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    STERIS plc (STE) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    STERIS (STE) trades at 24.1x trailing earnings and 4.1x sales. Its P/E of 24.1x is below its 5-year median of 25.0x. Its forward P/E is 23.2x. The median P/E across 9 similar companies is 16.9x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 3.9% higher over the next year. Its free cash flow yield is 3.7%.

    MultipleValue
    P/E (trailing)24.1x
    Forward P/E23.2x
    Price to sales4.1x
    Price to book3.5x
    EV/EBITDA16.1x
    Price to FCF27.2x
    EV/FCF28.7x
    PEG2.6
    FCF yield3.7%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 4.7% below 25.3x, its P/S is 8.9% below 4.5x and its P/B is in line.

    MultipleCurrent5-year median10-year median
    P/E24.1x25.0x25.3x
    P/S4.1x6.6x4.5x
    P/B3.5x3.6x3.5x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 18.9x in 2016 to 32.5x in 2021.

    Year endPriceP/EP/SP/B
    2025$253.5225.2x4.3x3.5x
    2024$205.5622.7x4.3x3.1x
    2023$219.8525.6x7.7x6.8x
    2022$184.6923.2x7.0x6.1x
    2021$243.4132.5x9.0x7.4x
    2020$189.5430.8x7.1x8.4x
    2019$152.4227.6x4.4x3.8x
    2018$106.8523.2x3.3x2.9x
    2017$87.4721.8x2.9x2.4x
    2016$67.3918.9x2.2x2.1x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About STE

    What is STE's forward P/E ratio?

    STERIS has a forward P/E ratio of 23.2x.

    Is STE stock overvalued?

    GNG's valuation label for STE is Undervalued. Its P/E of 24.1x compares with a median of 16.9x across 9 similar companies.

    What is STE's price to sales ratio?

    STERIS has a price to sales ratio of 4.1x.

    What is STERIS's average P/E ratio over 5 years?

    STERIS's median P/E over the last 5 years is 25.0x, from 60 month-end values through Oct 2026.

    What is STE's PEG ratio?

    STERIS has a PEG ratio of 2.6.